ZM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Buy ZM now for a tactical upside move, not a long-term “set-and-forget” entry. The trend is bullish (stacked moving averages) and sentiment/catalysts have improved sharply due to the Anthropic stake narrative and multiple price-target raises. With the stock at ~$92, the near-term setup favors a push back toward the $95.41 resistance (R1) and potentially $99.61 (R2) if momentum follows through. The main drawback is heavy insider selling recently, which caps conviction for a sustained multi-month breakout.
Price/Trend: Bullish trend structure with SMA_5 > SMA_20 > SMA_200, suggesting buyers are in control on multiple timeframes. Momentum: MACD histogram is positive (1.153) but contracting, implying upside momentum is still present but cooling after the recent run. RSI: RSI_6 ~60.4 (neutral-to-slightly-bullish), not indicating an extreme condition. Key levels: Pivot 88.61 is the key support to watch; near-term resistance is 95.41 (R1) and then 99.61 (R2). Pattern-based forward view: Model shows modest upside odds near-term (next week +1.62%) but softer one-month expectation (-2.67%), consistent with a near-term trade rather than a long hold.
Intellectia Proprietary Trading Signals
Narrative-driven catalyst: market focus on Zoom’s Anthropic investment potentially being worth multi-billions (value-holding-company angle), which has recently fueled a sharp sentiment shift.
Analyst momentum: multiple firms raised targets recently; bullish notes emphasize AI strategy resonance and improving enterprise/online trends.
Business stabilization signals: reports highlight low churn (~2.7% monthly) and incremental strength in >$100K customers.
Balance sheet flexibility (noted in news): substantial cash position supports buybacks/optionality.
Upcoming earnings date (2026-02-26 after hours) can serve as a catalyst window if results/guidance reinforce the re-acceleration narrative.
Insider behavior: Insiders are selling, with selling amount up ~3447.69% over the last month—this is the clearest bearish counter-signal in the dataset.
Overhang of “low-to-mid single digit” growth framing: several neutral-rated analysts still see limited near-term re-rating without clearer acceleration.
Technical overhead: nearby resistance at ~$95.41; failure to reclaim/hold above it can trigger a pullback toward the ~$88.61 pivot.
Elevated implied volatility: the market is pricing larger moves, which can coincide with sharper drawdowns as well as rallies.
Latest quarter: 2026/Q3. Revenue grew to $1.2298B (+4.44% YoY), indicating modest but improving top-line growth. Profitability surged: Net income $612.9M (+196% YoY) and EPS $2.01 (+204.55% YoY), alongside gross margin expansion to 77.9% (+2.65% YoY). Overall: fundamentals show a stabilization-to-improvement pattern with strong margin/profit leverage versus modest revenue growth.
Recent trend: Price targets have generally moved up from late 2025 into Jan 2026, with multiple reiterations/initiations on the Buy side (e.g., BTIG Buy $105; Jefferies Buy $105; Rosenblatt Buy $115; Wedbush Outperform $110 in news), while several large banks remain Neutral/Equal Weight with slightly raised targets (e.g., JPM $90 Neutral; Morgan Stanley $92 Equal Weight; Citi $94 Neutral; Piper $91 Neutral). Wall Street pros (bull case): AI/product strategy traction, stabilizing churn and enterprise improvements, buyback support, and the Anthropic stake as a meaningful hidden asset. Wall Street cons (bear case): growth still expected to be low-to-mid single digits near-term, limiting multiple expansion; and sentiment can fade if the Anthropic value narrative doesn’t translate into realized value. Influential/political trading: No recent congress trading data available. Hedge funds: Neutral. Insiders: Selling trend is notably negative.
